Catalyst Compounds GLP-1

Description

Semaglutide is a synthetic peptide research compound that functions as an agonist of the glucagon-like peptide-1 (GLP-1) receptor. It is studied as a reference incretin-pathway compound for metabolic investigations.

Reported research spans glucose regulation, insulin secretion dynamics, appetite-related behavioral assays, and GLP-1 receptor signaling in cell cultures and rodent models. Its defined receptor target supports mechanistic study of incretin biology.

Intended use: In vitro and preclinical in vivo laboratory research only. Not approved for human or veterinary use.